Home/Filings/4/A/0000899243-22-012855
4/A//SEC Filing

Annis Allen 4/A

Accession 0000899243-22-012855

CIK 0001420565other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 8:31 PM ET

Size

5.7 KB

Accession

0000899243-22-012855

Insider Transaction Report

Form 4/AAmended
Period: 2022-03-30
Annis Allen
10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2022-03-30+313,000313,000 total
    Exercise: $0.48Exp: 2032-03-29Common Stock (313,000 underlying)
Footnotes (2)
  • [F1]This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022.
  • [F2]The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026.

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1
  • filerCIK 0001709601

Filing Metadata

Form type
4/A
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 8:31 PM ET
Size
5.7 KB